Trial Profile
A Phase 2, Randomized Withdrawal Study of the Analgesic Efficacy and Safety of Hydrocodone/Acetaminophen Extended Release Compared to Placebo in Subjects With Chronic Low Back Pain.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Hydrocodone/paracetamol (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Sponsors AbbVie
- 30 Nov 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 30 Nov 2011 Actual patients number (166) added as reported by ClinicalTrials.gov.
- 30 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.